1. Fujii K, Minami N, Hayashi Y, Nishino I, Nonaka I, Tanabe Y, et al. Homozygous female Becker muscular dystrophy. Am J Med Genet A. 2009; 149A:1052–1055.
Article
2. Norman A, Harper P. A survey of manifesting carriers of Duchenne and Becker muscular dystrophy in Wales. Clin Genet. 1989; 36:31–37.
Article
3. Hoffman EP, Arahata K, Minetti C, Bonilla E, Rowland LP. Dystrophinopathy in isolated cases of myopathy in females. Neurology. 1992; 42:967–975.
Article
4. Hoogerwaard EM, Bakker E, Ippel PF, Oosterwijk JC, Majoor-Krakauer DF, Leschot NJ, et al. Signs and symptoms of Duchenne muscular dystrophy and Becker muscular dystrophy among carriers in The Netherlands: a cohort study. Lancet. 1999; 353:2116–2119.
Article
5. Song TJ, Lee KA, Kang SW, Cho H, Choi YC. Three cases of manifesting female carriers in patients with Duchenne muscular dystrophy. Yonsei Med J. 2011; 52:192–195.
Article
6. Cho YN, Choi YC. Female carriers of duchenne muscular dystrophy. J Genet Med. 2013; 10:94–98.
Article
7. Tasca G, Monforte M, Iannaccone E, Laschena F, Ottaviani P, Silvestri G, et al. Muscle MRI in female carriers of dystrophinopathy. Eur J Neurol. 2012; 19:1256–1260.
Article
8. Juan-Mateu J, Rodríguez MJ, Nascimento A, Jiménez-Mallebrera C, González-Quereda L, Rivas E, et al. Prognostic value of X-chromosome inactivation in symptomatic female carriers of dystrophinopathy. Orphanet J Rare Dis. 2012; 7:82.
Article
9. Seemann N, Selby K, McAdam L, Biggar D, Kolski H, Goobie S, et al. Symptomatic dystrophinopathies in female children. Neuromuscul Disord. 2011; 21:172–177.
Article
10. Cho H, Hong JM, Lee KA, Choi YC. Clinical usefulness of molecular diagnosis in dystrophin gene mutations using the multiplex ligation-dependent probe amplification (MLPA) method. J Korean Neurol Assoc. 2010; 28:22–26.
11. Yoshioka M, Yorifuji T, Mituyoshi I. Skewed X inactivation in manifesting carriers of Duchenne muscular dystrophy. Clin Genet. 1998; 53:102–107.
Article
12. Verellen-Dumoulin C, Freund M, De Meyer R, Laterre C, Frédéric J, Thompson MW, et al. Expression of an X-linked muscular dystrophy in a female due to translocation involving Xp21 and non-random inactivation of the normal X chromosome. Hum Genet. 1984; 67:115–119.
Article
13. Chelly J, Marlhens F, Le Marec B, Jeanpierre M, Lambert M, Hamard G, et al. De novo DNA microdeletion in a girl with Turner syndrome and Duchenne muscular dystrophy. Hum Genet. 1986; 74:193–196.
Article
14. Quan F, Janas J, Toth-Fejel S, Johnson DB, Wolford JK, Popovich BW. Uniparental disomy of the entire X chromosome in a female with Duchenne muscular dystrophy. Am J Hum Genet. 1997; 60:160–165.
15. Katayama Y, Tran VK, Hoan NT, Zhang Z, Goji K, Yagi M, et al. Co-occurrence of mutations in both dystrophin- and androgen-receptor genes is a novel cause of female Duchenne muscular dystrophy. Hum Genet. 2006; 119:516–519.
Article
16. Den Dunnen JT, Grootscholten PM, Bakker E, Blonden LA, Ginjaar HB, Wapenaar MC, et al. Topography of the Duchenne muscular dystrophy (DMD) gene: FIGE and cDNA analysis of 194 cases reveals 115 deletions and 13 duplications. Am J Hum Genet. 1989; 45:835–847.
17. Hu XY, Ray PN, Murphy EG, Thompson MW, Worton RG. Duplicational mutation at the Duchenne muscular dystrophy locus: its frequency, distribution, origin, and phenotypegenotype correlation. Am J Hum Genet. 1990; 46:682–695.
18. Yoon J, Kim SH, Ki CS, Kwon MJ, Lim MJ, Kwon SR, et al. Carrier woman of Duchenne muscular dystrophy mimicking inflammatory myositis. J Korean Med Sci. 2011; 26:587–591.
Article
19. Hoogerwaard EM, van der Wouw PA, Wilde AA, Bakker E, Ippel PF, Oosterwijk JC, et al. Cardiac involvement in carriers of Duchenne and Becker muscular dystrophy. Neuromuscul Disord. 1999; 9:347–351.
Article
20. Arahata K, Ishihara T, Kamakura K, Tsukahara T, Ishiura S, Baba C, et al. Mosaic expression of dystrophin in symptomatic carriers of Duchenne's muscular dystrophy. N Engl J Med. 1989; 320:138–142.
Article
21. Magri F, Govoni A, D'Angelo MG, Del Bo R, Ghezzi S, Sandra G, et al. Genotype and phenotype characterization in a large dystrophinopathic cohort with extended follow-up. J Neurol. 2011; 258:1610–1623.
Article
22. Griggs RC, Mendell JR, Brooke MH, Fenichel GM, Miller JP, Province M, et al. Clinical investigation in Duchenne dystrophy: V. Use of creatine kinase and pyruvate kinase in carrier detection. Muscle Nerve. 1985; 8:60–67.
Article
23. Soltanzadeh P, Friez MJ, Dunn D, von Niederhausern A, Gurvich OL, Swoboda KJ, et al. Clinical and genetic characterization of manifesting carriers of DMD mutations. Neuromuscul Disord. 2010; 20:499–504.
Article